(Total Views: 508)
Posted On: 09/30/2022 9:11:13 AM
Post# of 157480
He’s 100 percent spot on. We don’t have the money time or resources anymore or did.
“will not be pursuing Covid treatment, either in acute setting or in the long hauler setting. We will not be pursuing GVHD. We will not be pursuing Stroke. We will not be pursuing Multiple Sclerosis”
Get one approval and the rest will follow.
“will not be pursuing Covid treatment, either in acute setting or in the long hauler setting. We will not be pursuing GVHD. We will not be pursuing Stroke. We will not be pursuing Multiple Sclerosis”
Get one approval and the rest will follow.
(2)
(0)
Daniel Rizzo
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf
